| Product Name | delta PKC (8-17); PKC d Inhibitor |
| Purity | HPLC>95% |
| Description | The peptide is derived from the V1 domain of protein kinase C (PKC)d. It inhibits the translocation and activation of PKCd induced by Fubo 12-myristate 13-acetate (PMA). Inhibition of PKCd can reduce the ischemic damage of myocardial and brain cells, induce the proliferation of fibroblasts, and inhibit coronary artery disease after transplantation in mice. |
| Storage | -20°C |
| References | Bright, R. et al. J Neurosci 24, 6880 (2004). Tanaka, M. et al. Circulation 110, 194 (2004). Braun, M and D. Mochly-Rosen. J Mol Cell Cardiol 35 895 (2003). Chen, L. et al. Proc Natl Acad Sci USA 98, 11114 (2001). |
| Molecular Weight | 1116.2 |
| Sequence (One-Letter Code) | SFNSYELGSL |
| Sequence (Three-Letter Code) | H - Ser - Phe - Asn - Ser - Tyr - Glu - Leu - Gly - Ser - Leu - OH |
delta PKC (8-17); PKC d InhibitorAdmin2021-01-07T09:15:58+00:00
